Sangamo Therapeutics, Inc (SGMOQ) is the 124th largest of 174 Gene and Cell Therapy companies by market capitalisation, at 43.43 Mn, behind Metagenomi Therapeutics, Inc. at 44.06 Mn. The table below compares all 174 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KRYS | Krystal Biotech, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 10.13 Bn | 41.94 | 22.99 | 9.28 Bn |
| 2 | CRSP | CRISPR Therapeutics AG | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 5.19 Bn | -10.74 | 387.80 | 5.19 Bn |
| 3 | IOVA | Iovance Biotherapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 3.89 Bn | -18.61 | 11.97 | 3.59 Bn |
| 4 | LEGN | Legend Biotech Corp | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 3.66 Bn | -173.71 | 2.88 | 2.69 Bn |
| 5 | QURE | uniQure N.V. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 3.05 Bn | -15.49 | 163.16 | 3.05 Bn |
| 6 | BEAM | Beam Therapeutics Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 2.63 Bn | -30.81 | 16.87 | 2.63 Bn |
| 7 | PGEN | Precigen, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 2.40 Bn | -7.14 | 28.04 | 2.40 Bn |
| 8 | SRPT | Sarepta Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 2.34 Bn | -17.08 | 1.19 | 1.55 Bn |
| 9 | VCEL | Vericel Corp | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.98 Bn | 79.04 | 6.47 | 1.82 Bn |
| 10 | TSHA | Taysha Gene Therapies, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.96 Bn | -13.07 | 356.60 | 1.96 Bn |
| 11 | NTLA | Intellia Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.64 Bn | -4.11 | 27.55 | 1.64 Bn |
| 12 | SLDB | Solid Biosciences Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.39 Bn | -6.83 | — | 1.39 Bn |
| 13 | MGTX | MeiraGTx Holdings plc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.24 Bn | 7.48 | 3.08 | 1.09 Bn |
| 14 | IMTX | Immatics N.V. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.14 Bn | -4.73 | 23.46 | 0.68 Bn |
| 15 | FDMT | 4D Molecular Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.00 Bn | -5.60 | 10.91 | 0.64 Bn |
| 16 | SANA | Sana Biotechnology, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.95 Bn | -4.42 | — | 0.95 Bn |
| 17 | CADL | Candel Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.92 Bn | -13.97 | — | 0.92 Bn |
| 18 | NGNE | Neurogene Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.87 Bn | -7.76 | — | 0.87 Bn |
| 19 | IMMX | Immix Biopharma, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.82 Bn | -25.82 | — | 0.82 Bn |
| 20 | PRME | Prime Medicine, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.60 Bn | -3.17 | 146.42 | 0.60 Bn |
| 21 | ALLO | Allogene Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.58 Bn | -3.51 | 125.55 | 0.58 Bn |
| 22 | BNTC | Benitec Biopharma Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.57 Bn | -12.25 | — | 0.57 Bn |
| 23 | AUTL | Autolus Therapeutics plc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.55 Bn | -2.15 | 4.92 | 0.35 Bn |
| 24 | IRD | Opus Genetics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.55 Bn | -5.65 | 55.71 | 0.46 Bn |
| 25 | CAPR | Capricor Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.52 Bn | -4.11 | — | 0.52 Bn |
| 26 | KYTX | Kyverna Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.47 Bn | -3.10 | — | 0.47 Bn |
| 27 | CABA | Cabaletta Bio, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.47 Bn | -2.55 | — | 0.47 Bn |
| 28 | RGNX | REGENXBIO Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.46 Bn | -2.60 | 2.43 | 0.35 Bn |
| 29 | ARTV | Artiva Biotherapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.43 Bn | -4.70 | — | 0.43 Bn |
| 30 | IPSC | Century Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -3.82 | — | 0.16 Bn |
| 31 | RCKT | Rocket Pharmaceuticals, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.41 Bn | -23.84 | — | 0.41 Bn |
| 32 | LXEO | Lexeo Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.39 Bn | -4.49 | — | 0.39 Bn |
| 33 | OCGN | Ocugen, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.39 Bn | -4.74 | 84.67 | 0.29 Bn |
| 34 | PROK | Prokidney Corp. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.35 Bn | -2.65 | 432.19 | 0.35 Bn |
| 35 | ABEO | Abeona Therapeutics Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.33 Bn | -3.05 | 12.94 | 0.18 Bn |
| 36 | LYEL | Lyell Immunopharma, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.31 Bn | -1.26 | 11,457.01 | 0.31 Bn |
| 37 | CLLS | Cellectis S.A. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.31 Bn | -7.42 | 5.23 | 0.14 Bn |
| 38 | FATE | Fate Therapeutics Inc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | -2.35 | 45.35 | 0.29 Bn |
| 39 | NWBO | Northwest Biotherapeutics Inc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.28 Bn | -7.14 | 127.74 | 0.28 Bn |
| 40 | LCTX | Lineage Cell Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.26 Bn | -11.37 | 19.93 | 0.20 Bn |
| 41 | RNAC | Cartesian Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.26 Bn | -2.40 | 176.26 | 0.26 Bn |
| 42 | EDIT | Editas Medicine, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.25 Bn | — | — | 0.10 Bn |
| 43 | MEOBF | Mesoblast Ltd | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.25 Bn | -4.28 | 2.05 | 0.14 Bn |
| 44 | TARA | Protara Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.24 Bn | -3.39 | — | 0.24 Bn |
| 45 | NKTX | Nkarta, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.23 Bn | -1.58 | — | 0.23 Bn |
| 46 | VYGR | Voyager Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.20 Bn | -2.37 | 5.65 | 0.08 Bn |
| 47 | DTIL | Precision Biosciences Inc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -5.60 | 4.22 | 0.10 Bn |
| 48 | ZSQR | Z Squared Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -8.03 | 55.33 | 0.14 Bn |
| 49 | ATRA | Atara Biotherapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -6.51 | 24.71 | 0.14 Bn |
| 50 | CRBU | Caribou Biosciences, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -1.36 | 14.84 | 0.04 Bn |
| 51 | TNYA | Tenaya Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -1.43 | 110.12 | 0.15 Bn |
| 52 | HUMA | Humacyte, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -1.15 | 64.59 | 0.14 Bn |
| 53 | ENGN | enGene Therapeutics Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -1.01 | — | 0.13 Bn |
| 54 | ACET | Adicet Bio, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -1.04 | — | -0.01 Bn |
| 55 | ANIX | Anixa Biosciences Inc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -9.22 | — | 0.10 Bn |
| 56 | INMB | Inmune Bio, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.07 Bn | -3.34 | — | 0.05 Bn |
| 57 | INKT | MiNK Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -5.21 | — | 0.06 Bn |
| 58 | APTN | Adaptin Bio, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -10.22 | — | 0.06 Bn |
| 59 | MGX | Metagenomi Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.47 | 2.02 | 0.04 Bn |
| 60 | SGMOQ | Sangamo Therapeutics, Inc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.35 | 1.10 | 0.02 Bn |
| 61 | TCRX | TScan Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.36 | 6.03 | 0.04 Bn |
| 62 | CELU | Celularity Inc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.41 | 1.43 | 0.03 Bn |
| 63 | ESLA | Estrella Immunopharma, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -4.02 | — | 0.03 Bn |
| 64 | TVGN | Tevogen Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -1.24 | — | 0.03 Bn |
| 65 | MRKR | Marker Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -2.38 | — | 0.01 Bn |
| 66 | INAB | In8Bio, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.20 | — | 0.02 Bn |
| 67 | LGVN | Longeveron Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.89 | 17.63 | 0.01 Bn |
| 68 | GNTA | Genenta Science S.p.A. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -3.87 | — | 0.02 Bn |
| 69 | PASG | Passage BIO, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.38 | — | 0.01 Bn |
| 70 | ADIA | Adia Nutrition, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -75.51 | 69.62 | 0.01 Bn |
| 71 | PLUR | Pluri Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | 0.00 | 8.64 | 0.00 Bn |
| 72 | FBLG | FibroBiologics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.65 | — | 0.01 Bn |
| 73 | GDTC | CytoMed Therapeutics Ltd | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -3.25 | 40.49 | 0.01 Bn |
| 74 | SNTI | Senti Biosciences Holdings, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.14 | 546.50 | 0.01 Bn |
| 75 | ZEOX | Zeo ScientifiX, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -2.03 | 1.22 | 0.01 Bn |
| 76 | LNAI | Lunai Bioworks Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.06 | 95.68 | 0.00 Bn |
| 77 | PMCB | PharmaCyte Biotech, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.18 | — | 0.00 Bn |
| 78 | TPST | Tempest Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.25 | — | 0.00 Bn |
| 79 | MBIO | Mustang Bio, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.20 | — | 0.00 Bn |
| 80 | ISCO | International Stem Cell CORP | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -9.91 | 0.33 | 0.00 Bn |
| 81 | CLDI | Calidi Biotherapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.08 | — | 0.00 Bn |
| 82 | GNPX | Genprex, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | -0.01 Bn |
| 83 | CELZ | Creative Medical Technology Holdings, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.20 | 491.94 | 0.00 Bn |
| 84 | BRTX | BioRestorative Therapies, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.08 | 3.53 | 0.00 Bn |
| 85 | RMTG | Regenerative Medical Technology Group Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.12 | 0.13 | 0.00 Bn |
| 86 | ERNAW | Ernexa Therapeutics Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | — | 0.00 Bn |
| 87 | JNJ | Johnson & Johnson | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 642.97 Bn | 30.56 | 6.57 | 622.21 Bn |
| 88 | TMO | Thermo Fisher Scientific Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 224.81 Bn | 31.93 | 4.85 | 220.75 Bn |
| 89 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 181.12 Bn | -62.56 | 5.95 | 177.94 Bn |
| 90 | DHR | Danaher Corp /De/ | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 144.40 Bn | 36.19 | 5.75 | 140.05 Bn |
| 91 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 132.11 Bn | 29.99 | 10.50 | 124.26 Bn |
| 92 | BDX | Becton Dickinson & Co | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 49.33 Bn | 52.36 | 2.12 | 48.46 Bn |
| 93 | IDXX | Idexx Laboratories Inc /De | secondary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 40.89 Bn | 35.88 | 8.98 | 40.69 Bn |
| 94 | A | Agilent Technologies, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 40.84 Bn | 28.36 | 5.54 | 39.08 Bn |
| 95 | ILMN | Illumina, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 31.36 Bn | 38.01 | 6.98 | 30.19 Bn |
| 96 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 30.09 Bn | -20.28 | 2,754.96 | 30.09 Bn |
| 97 | IR | Ingersoll Rand Inc. | secondary | I-10 | Machinery | IG-02 | 28.85 Bn | 29.86 | 3.63 | 27.67 Bn |
| 98 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 28.32 Bn | -32.35 | 24.89 | 27.16 Bn |
| 99 | MTD | Mettler Toledo International Inc/ | secondary | I-04 | Machinery | IG-02 | 26.10 Bn | 28.82 | 6.31 | 26.05 Bn |
| 100 | UTHR | UNITED THERAPEUTICS Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 21.44 Bn | 16.35 | 6.80 | 18.78 Bn |
| 101 | STE | STERIS plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 21.13 Bn | 26.15 | 3.50 | 20.65 Bn |
| 102 | NBIX | Neurocrine Biosciences Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.52 Bn | 22.00 | 4.60 | 15.13 Bn |
| 103 | RVTY | Revvity, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 13.65 Bn | 57.48 | 4.69 | 12.63 Bn |
| 104 | CRL | Charles River Laboratories International, Inc. | secondary | H-11 | Pharma Services | HG-03 | 13.36 Bn | -56.19 | 3.34 | 13.16 Bn |
| 105 | BMRN | Biomarin Pharmaceutical Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 12.53 Bn | 171.75 | 3.68 | 11.66 Bn |
| 106 | TECH | BIO-TECHNE Corp | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 11.27 Bn | 61.99 | 9.28 | 11.01 Bn |
| 107 | DCI | DONALDSON Co INC | secondary | I-04 | Machinery | IG-02 | 10.40 Bn | 23.69 | 2.73 | 10.19 Bn |
| 108 | BIO | Bio-Rad Laboratories, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 10.08 Bn | 45.34 | 3.89 | 8.47 Bn |
| 109 | RGEN | Repligen Corp | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 9.44 Bn | 152.95 | 12.03 | 8.43 Bn |
| 110 | TXG | 10x Genomics, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 8.65 Bn | -115.13 | 14.02 | 8.10 Bn |
| 111 | IBRX | ImmunityBio, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 8.45 Bn | -8.52 | 50.99 | 8.10 Bn |
| 112 | BRKR | Bruker Corp | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 8.29 Bn | -77.58 | 2.37 | 8.08 Bn |
| 113 | TGTX | Tg Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 7.73 Bn | 17.50 | 9.67 | 7.05 Bn |
| 114 | TWST | Twist Bioscience Corp | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 7.72 Bn | -56.48 | 17.88 | 7.56 Bn |
| 115 | GIFLF | Grifols SA | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 7.54 Bn | 29.70 | 0.46 | 9.09 Bn |
| 116 | GRAL | GRAIL, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 3.39 Bn | -8.64 | 21.53 | 2.52 Bn |
| 117 | NKTR | Nektar Therapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.43 Bn | -20.48 | 44.59 | 1.75 Bn |
| 118 | GLPGF | Lakefront Biotherapeutics NV | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.73 Bn | 0.00 | 1.50 | 1.73 Bn |
| 119 | BLFS | Biolife Solutions Inc | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 1.72 Bn | 29.75 | 16.77 | 1.64 Bn |
| 120 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.50 Bn | -3.24 | 2.09 | 1.21 Bn |
| 121 | AZTA | Azenta, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 1.38 Bn | -4.40 | 1.31 | 1.06 Bn |
| 122 | MRVI | Maravai Lifesciences Holdings, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 1.03 Bn | -7.59 | 4.94 | 0.96 Bn |
| 123 | PCRX | Pacira BioSciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.01 Bn | 68.91 | 1.35 | 0.76 Bn |
| 124 | CYRX | Cryoport, Inc. | secondary | I-22 | Transportation | IG-05 | 0.78 Bn | -17.08 | 4.16 | 0.38 Bn |
| 125 | MLAB | Mesa Laboratories Inc /Co/ | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.70 Bn | 199.76 | 2.81 | 0.67 Bn |
| 126 | CTKB | Cytek Biosciences, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.60 Bn | -7.44 | 2.90 | 0.53 Bn |
| 127 | OABI | OmniAb, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.52 Bn | -11.67 | 13.43 | 0.46 Bn |
| 128 | NEUP | Neuphoria Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.47 Bn | -19.80 | — | 0.45 Bn |
| 129 | DNA | Ginkgo Bioworks Holdings, Inc. | secondary | H-11 | Pharma Services | HG-03 | 0.42 Bn | -1.45 | 3.77 | 0.34 Bn |
| 130 | PACB | Pacific Biosciences Of California, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.41 Bn | -3.09 | 2.55 | 0.17 Bn |
| 131 | TKNO | Alpha Teknova, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.38 Bn | -28.86 | 8.67 | 0.36 Bn |
| 132 | MASS | 908 Devices Inc. | secondary | I-02 | Aerospace and Defense | IG-01 | 0.36 Bn | -13.10 | 5.97 | 0.26 Bn |
| 133 | AGEN | Agenus Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.29 Bn | 3.18 | 2.20 | 0.29 Bn |
| 134 | LAB | Standard Biotools Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.28 Bn | 3.33 | 3.34 | -0.19 Bn |
| 135 | ALEC | Alector, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.26 Bn | -2.98 | 18.85 | 0.09 Bn |
| 136 | OSUR | Orasure Technologies Inc | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.24 Bn | — | 2,431.03 | 0.04 Bn |
| 137 | CELG-RI | Bristol Myers Squibb Co | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.23 Bn | 0.02 | 0.00 | -10.84 Bn |
| 138 | QSI | Quantum-Si Inc | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.16 Bn | -1.66 | 102.20 | 0.16 Bn |
| 139 | NAUT | Nautilus Biotechnology, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.14 Bn | -4.25 | 602.64 | 0.14 Bn |
| 140 | MXCT | Maxcyte, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.13 Bn | -3.73 | 4.28 | 0.13 Bn |
| 141 | HURA | TuHURA Biosciences, Inc./NV | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -4.30 | — | 0.13 Bn |
| 142 | CDXS | Codexis, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.13 Bn | -4.27 | 1.69 | 0.08 Bn |
| 143 | QTRX | Quanterix Corp | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.12 Bn | -1.02 | 0.81 | 0.03 Bn |
| 144 | GUTS | Fractyl Health, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.11 Bn | -0.85 | — | 0.11 Bn |
| 145 | SEER | Seer, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.11 Bn | -2.04 | 7.53 | 0.11 Bn |
| 146 | PLYX | Polaryx Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -10.06 | — | 0.09 Bn |
| 147 | FBIO | Fortress Biotech, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.08 Bn | 10.01 | 1.21 | -0.11 Bn |
| 148 | RPID | Rapid Micro Biosystems, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.06 Bn | -1.16 | 1.69 | 0.04 Bn |
| 149 | JANL | Janel Corp | secondary | I-22 | Transportation | IG-05 | 0.06 Bn | 10.85 | 0.25 | 0.03 Bn |
| 150 | IMMP | IMMUTEP Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.43 | 5.09 | 0.05 Bn |
| 151 | SER | Serina Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -1.48 | 321.40 | 0.02 Bn |
| 152 | ATNM | Actinium Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | 3.46 | 1.11 | 0.04 Bn |
| 153 | HBIO | Harvard Bioscience Inc | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.04 Bn | 41.55 | 0.41 | 0.03 Bn |
| 154 | VRXA | Veraxa Biotech AG - Post de-SPAC | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.30 | 869.19 | 0.02 Bn |
| 155 | DYAI | Dyadic International Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -2.59 | 4.86 | 0.01 Bn |
| 156 | CTXR | Citius Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.34 | 2.18 | 0.02 Bn |
| 157 | BNGO | Bionano Genomics, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -0.53 | 0.46 | 0.00 Bn |
| 158 | ADVB | Advanced Biomed Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | 2.44 | — | 0.01 Bn |
| 159 | SCND | Scientific Industries Inc | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -12.86 | 1.67 | 0.00 Bn |
| 160 | CDIO | Cardio Diagnostics Holdings, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -0.90 | 403.31 | 0.00 Bn |
| 161 | CLGN | CollPlant Biotechnologies Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.63 | 10.67 | 0.00 Bn |
| 162 | HCWB | HCW Biologics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.09 | 17.90 | 0.00 Bn |
| 163 | CASIF | CASI Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.02 | 0.12 | 0.00 Bn |
| 164 | BCAB | BioAtla, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.07 | 0.27 | 0.00 Bn |
| 165 | POAS | PHAOS TECHNOLOGY HOLDINGS (CAYMAN) Ltd | secondary | I-04 | Machinery | IG-02 | 0.00 Bn | 0.00 | 0.00 | 0.00 Bn |
| 166 | ISPC | iSpecimen Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | -0.22 | 4.55 | 0.00 Bn |
| 167 | GOVX | GeoVax Labs, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.10 | 2.44 | 0.00 Bn |
| 168 | BJDX | Bluejay Diagnostics, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | -0.26 | — | 0.00 Bn |
| 169 | RNAZ | Transcode Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.04 | — | 0.00 Bn |
| 170 | NUMD | Nu-Med Plus, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | -100.79 | — | 0.00 Bn |
| 171 | VNRX | Volitionrx Ltd | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | -0.09 | 0.62 | 0.00 Bn |
| 172 | BNBX | Bnb Plus Corp. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | -0.03 | 0.48 | 0.00 Bn |
| 173 | GRMLW | Greenland Mines Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.02 | — | -0.01 Bn |
| 174 | NOTVQ | Inotiv, Inc. | secondary | H-11 | Pharma Services | HG-03 | 0.00 Bn | 0.00 | 0.00 | -0.01 Bn |